Evidence map›Paper›PMID 33822051›Full record

ArticleGlycobiology2022

Influence of saccharide modifications on heparin lyase III substrate specificities.

Jiandong Wu, Pradeep Chopra, Geert-Jan Boons, Joseph Zaia

Open access · bronzeAbstract read
In one paragraph

Article in Glycobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Heparinase Digestion of 3-Frontiers in medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jiandong WuDepartment of Biochemistry, Center for Biomedical Mass Spectrometry, Boston University School of Medicine, Boston, MA 02118, USA.
Pradeep ChopraDepartment of Biochemistry, Center for Biomedical Mass Spectrometry, Boston University School of Medicine, Boston, MA 02118, USA.
Geert-Jan BoonsComplex Carbohydrate Research Center, University of Georgia, Athens, GE 30602, USA.
Joseph ZaiaDepartment of Biochemistry, Center for Biomedical Mass Spectrometry, Boston University School of Medicine, Boston, MA 02118, USA.
Boston University · USUtrecht University · NL

Funding

TR&D3. Approaches to Proteoglycan Function at Biochemical and Cellular LevelsP41GM103390 · NIGMS · UNIVERSITY OF GEORGIA · PI MOREMEN, KELLEY W. · 2012 to 2019
$14.5M
Mass Spectrometry Resource for Biology and MedicineP41GM104603 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2012 to 2017
$10.4M
3-O-sulfation of heparan sulfate as a regular of protein functionR01HL151617 · NHLBI · UNIVERSITY OF GEORGIA · PI BOONS, GEERT-JAN, MOREMEN, KELLEY W. · 2020 to 2023
$1.8M
Methods for determination of glycoprotein glycosylation similarities among disease statesR01GM133963 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ZAIA, JOSEPH · 2019 to 2021
$1.4M
An open-source software suite for processing glycomics and glycoproteomics mass spectral dataU01CA221234 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ZAIA, JOSEPH · 2017 to 2019
$1.2M
Software for automated interpretation of heparan sulfate tandem mass spectraR21HL131554 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ZAIA, JOSEPH · 2015 to 2016
$761k
NCI NIH HHS U01 CA221234NHLBI NIH HHS R01 HL151617NHLBI NIH HHS R21 HL131554NIGMS NIH HHS P41 GM103390NIGMS NIH HHS P41 GM104603NIGMS NIH HHS R01 GM133963
6 · The paper itself

Abstract

A library of 23 synthetic heparan sulfate (HS) oligosaccharides, varying in chain length, types, and positions of modifications, was used to analyze the substrate specificities of heparin lyase III enzymes from both Flavobacterium heparinum and Bacteroides eggerthii. The influence of specific modifications, including N-substitution, 2-O sulfation, 6-O sulfation, and 3-O sulfation on lyase III digestion was examined systematically. It was demonstrated that lyase III from both sources can completely digest oligosaccharides lacking O-sulfates. 2-O Sulfation completely blocked cleavage at the corresponding site; 6-O and 3-O sulfation on glucosamine residues inhibited enzyme activity. We also observed that there are differences in substrate specificities between the two lyase III enzymes for highly sulfated oligosaccharides. These findings will facilitate obtaining and analyzing the functional sulfated domains from large HS polymer, to better understand their structure/function relationships in biological processes.

Indexed as

Heparan SulfateOligosaccharidesHeparinHeparin LyaseSubstrate SpecificitySulfatesHeparan SulfateHeparinHeparin LyaseOligosaccharidesSulfatesglycomicsglycosaminoglycansheparan sulfateheparin lyasemass spectrometry

Identifiers

PMID33822051
PMCPMC8966481
OpenAlexW3151697627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.